 HYDERABAD, India--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124 NSE: DRREDDY NYSE: RDY today announced its consolidated financial results for the quarter and the half year ended September 30, 2020. The information mentioned in this release is on the basis of consolidated financial statements under International Financial Reporting Standards IFRS. Q2 Performance Summary H1 Performance Summary Rs. 4,897 Cr Rs. 9,314 Cr Revenue Revenue Up: 11 QoQ; 2 YoY Up: 8 YoY 53 